| Application no. and date | 12182790.1 (espacenet) (Federated) (European Patent Register), 20080918 | | Patent/reg. no. and date | DK/EP 2533047, 20160511 | | Publication date | 20121212 | | Priority no. and date | GB 0718167, 20070918 | | EP pub. no. and date |
EP 2533047 20121212 | | Effective date | | | Applicant/owner | Cancer Research Technology Limited, Angel Building 407 St John Street London
EC1V 4AD, GB | | Applicant ref. no. | P53318DK02 | | Inventor | Slettenaar, Violet, Barts Cancer Institute
Queen Mary University of London
Charterhouse Square
London EC1M 6BQ, GB,
Wilson, Julia, Barts Cancer Institute
Queen Mary University of London
Charterhouse Square
London EC1M 6BQ, GB,
Wang, Yaohe, Barts Cancer Institute
Queen Mary University of London
Charterhouse Square
London EC1M 6BQ, GB,
Schioppa, Tiziana, Barts Cancer Institute
Queen Mary University of London
Charterhouse Square
London EC1M 6BQ, GB,
Balkwill, Frances, Barts Cancer Institute
Queen Mary University of London
Charterhouse Square
London EC1M 6BQ, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , G01N 33/50 (2006.01) , G01N 33/574 (2006.01) | | Title | CCR4 som terapeutisk mål for cancer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
